Telomerase activation in human fibroblasts during escape from crisis

Journal of Cellular Physiology

Volumn 180, Issue 1, 1999, Pages 46-52

  Montalto, Michael C ^a   Phillips, Jennifer S ^a   Ray, F Andrew ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CELL CYCLE; CELL IMMORTALIZATION; DIPLOIDY; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SENESCENCE; TELOMERE;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL AGING; CELL DIVISION; CELL LINE, TRANSFORMED; CELL LINEAGE; DNA PRIMERS; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; TELOMERASE; TELOMERE;

EID: 0032967560     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199907)180:1<46::AID-JCP5>3.0.CO;2-K     Document Type: Article

References (46)

1. Allsopp RC, Barley CB. 1995. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219:130-136.
2. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. 1996. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56:645-650.
3. Bacchetti S, Counter CM. 1995. Telomeres and telomerase in human cancer (review). Int J Oncol 7:423-432.
4. Bischoff FZ, Yim SO, Pathak S, Grant G, Giovanella BC, Strong LC, Tainsky MA. 1990. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res 50:7979-7984.
5. Bodner AG, Ouellette M, Frolkis M, Holt SE, Chiu C, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-335.
6. Bryan TM, Reddel RR. 1997. Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33:767-773.
7. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel R. 1995. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14:4240-4248.
8. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. 1997. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med 3:1271-1274.
9. Chang E, Harley CB. 1995. Telomere length and replicative aging in human vascular tissue. Proc Natl Acad Sci USA 92:11190-11194.
10. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921-1929.
11. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. 1995. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315-2320.
12. Filatov L, Golubovskaya V, Hurt JC, Byrd LL, Phillips JM, Kaufmann WK. 1998. Chromosomal instability is correlated with telomere erosion and inactivatoin of G2 checkpoint function in human fibroblasts expressing haman papillomavirus type 16 E6 oncoprotein. Oncogene 16:1825-1838.
13. Gollahon LS, Kraus E, Wu T, Yim SO, Strong LC, Shay JW, Tainsky MA. 1998. Telomerase activity during the spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts. Oncogene 17: 709-717.
14. Greider CW. 1996. Telomere length regulation. Annu Rev Biochem 65:337-366.
15. Harley CB, Futcher AB, Greider CW. 1990. Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460.
16. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. 1990. Telomere reduction in human colorectal carcinoma and with aging. Nature 346:866-868.
17. Hayflick L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37:614-636.
18. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
19. Klingelhutz AJ, Foster SA, McDougall JK. 1996. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79-82.
20. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
21. Montalto MC, Ray FA. 1996. Telomerase activation during the linear evolution of human fibroblasts to tumorigenicity in nude mice. Carcinogenesis 17:2631-2634.
22. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW. 1999. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Gen 21:115-118.
23. Morin GB. 1989. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesises TTAGGG repeats. Cell 59: 521-529.
24. Murnane JP, Sabatier L, Marder B, Morgan WF. 1994. Telomere dynamics in an immortal human cell line. EMBO J 13:4953-4962.
25. Nakabayshi K, Ogata T, Fujii M, Tahara H, Ide T, Wadhwa R, Kaul SC, Mitsui Y, Ayusawa D. 1997. Decrease in amplified telomeric sequence and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp Cell Res 235:345-353.
26. Ogino H, Nakabayshi K, Suzuki M, Takahashi E, Fujii M, Suzuki T, Ayusawa D. 1998. Release of telomeric DNA from chromosome in immortal human cells lacking telomerase activity. Biochem Biophys Res Commun 248:223-227.
27. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, Tahara E, Shay JW, Barrett CJ, Oshima M. 1995. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 86:899-904.
28. Pandita TK, Hall EJ, Hei TK, Piatyszek MA, Wright WE, Piao CQ, Pandita RK, Willey JC, Geard CR, Kastan MB, Shay JW. 1996. Chromosome end-to-end associations and telomerase activity during cancer progressions in human cells after treatment with α-particles simulating radon progeny. Oncogene 13:1423-1430.
29. Ray FA, Kraemer P. 1992. Frequent deletions in nine newly immortal human cell lines. Cancer Genet Cytogenet 59:39-44.
30. Ray FA, Kraemer P. 1993. Iterative chromosome mutation and selection as a mechanism of complete transformation of human diploid fibroblasts by SV40 T antigen. Carcinogenesis 14:1511-1516.
31. Ray FA, Peabody DS, Cooper JL, Cram LS, Kraemer PM. 1990. SV40 T antigen alone drives karyotype instability which precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem 42:13-31.
32. Ray FA, Meyne J, Kraemer PM. 1992. SV40 T antigen induced chromosomal changes reflect a process that is both clastogenic and aneuploidogenic and is ongoing throughout neoplastic progression of human fibroblasts. Mutat Res 284:265-273.
33. Shay JW, Wright WE. 1989. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res 184:109-118.
34. Shay JW, Van Der Haegen BA, Ying Y, Wright WE. 1993. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 209:45-52.
35. Shay JW, Tomlinson G, Piatysek MA, Gollahon LS. 1995. Spontaneous in vitro immoralization of breast epithelial cells from a patient with Li-Fraumihi syndrome. Moll Cell Biol 15:425-432.
36. Shiga T, Shirasawa H, Shimizu K, Dezawa M, Masuda Y, Simizu B. 1997. Normal human fibroblasts immortalized by introduction of human papillomavirus type 16 (HPV-16) E6-E7 genes. Microbiol Immunol 41:313-319.
37. Small MB, Hubbard K, Pardinas JR, Marcus AM, Dhanaraj SN, Sethi KA. 1996. Maintenance of telomeres in SV40-transformed pre-immortal and immortal human fibroblasts. J Cell Physiol 168:727-736.
38. Stein GH. 1985. SV40-transformed human fibroblasts: evidence for cellular aging in precrisis cells. J Cell Physiol 184:109-118.
39. Tsutsui T, Fujino T, Kodama S, Tainsky MA, Boyd J, Barrett JC. 1995. Aflatoxin B1-induced immortalization of cultured skin fibroblasts from a patient with Li-Fraumeni syndrome. Carcinogenesis 16:25-34.
40. Tsutsui T, Tanaka Y, Matsudo Y, Hasegawa K, Fujino T, Kodama S, Barrett JC. 1997. Extended lifespan and immortalization of human fibroblasts induced by X-ray irradiation. Mol Carcinogen 18:7-18.
41. Wang J, Xie YL, Allan S, Beach D, Hannon GJ. 1998. Myc activates telomerase. Genes Dev 12:1769-1774.
42. Wen J, Cong Y, Bacchetti S. 1998. Reconsitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells. Hum Mol Genet 7:1137-1141.
43. Wright WE, Pereira-Smith OM, Shay JW. 1989. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 9:3088-3092.
44. Wright WE, Shay JW, Piatyszek MA. 1995. Modifications of telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23:3794-3795.
45. Wright WE, Brasiskyte D, Piatyszek MA, Shay JW. 1996. Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J 15:1734-1741.
46. Xia SJ, Shammas MA, Reis RJ. 1996. Reduced telomere length in ataxia-telangiectasia fibroblasts. Mutat Res 364:1-11.